IGF2 and Alzheimer disease: We therefore analysed the expression of IGF2 in AD brains and employed an adeno-associated viral (AAV) vector gene-delivery system to express IGF2 in the hippocampus of the transgenic mouse model Tg2576 to test their effect on the behavioural, cellular and synaptic phenotypes typical of AD.